Investigation on the Effect and Safety of Camrelizumab in the Treatment of Patients with Advanced Hepatocellular Carcinoma and Influence on Antitumor Immunity

LUO Meidi; WANG Shuiping; SHI Lanling

doi:10.14033/j.cnki.cfmr.2022.33.002

Home>Articles>Investigation on the Effect and Safety of Camrelizumab in the Treatment of Patients with Advanced Hepatocellular Carcinoma and Influence on Antitumor Immunity

DOI: 10.14033/j.cnki.cfmr.2022.33.002

Investigation on the Effect and Safety of Camrelizumab in the Treatment of Patients with Advanced Hepatocellular Carcinoma and Influence on Antitumor Immunity

LUO Meidi

WANG Shuiping

SHI Lanling

Machine-generated Keywords：

Publication Date：2022-11-25

Online Publishing Date：2025-08-15(First online date of this platform, not the publication date of the document)

Pages：5( 5-9 )

Chinese and Foreign Medical Research

ISSN：1674-6805

Year, Vol.(Issue)：2022,20(33)